FDAFDA recall D-0165-2027 · Nov 11, 2026
Hikma Pharmaceuticals USA INC.: Ciprofloxacin Tablets recall
Quick answer
- Product
- Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01
- Brand
- Hikma Pharmaceuticals USA INC.
- Codes, lots and dates
- Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026
- Hazard
- CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
- Distribution
- US Nationwide
- Quantity
- 29,085 bottles
- Recall date
- Nov 11, 2026
- Agency
- U.S. Food and Drug Administration (FDA) enforcement report
- Recall number
- D-0165-2027
Recall found
Product
Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01
Reason for recall
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
| Quantity | 29,085 bottles |
|---|---|
| Codes, lots and dates | Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026 |
| Distribution | US Nationwide |
| Recall date | Nov 11, 2026 |
| Class | Class II |
| Agency ID | D-0165-2027 |
| Official notice | U.S. Food and Drug Administration (FDA) enforcement report |
| Data as of, last checked | Nov 21, 2026, 3:48 PM EST |
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026
- Quantity
- 29,085 bottles
- Distribution
- US Nationwide
- Recalling firm
- Hikma Pharmaceuticals USA INC., Columbus, OH
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-10-20
Source: openFDA enforcement record D-0165-2027 · search recall number D-0165-2027 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.
FAQ
What was recalled?
Product: Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01 Brand: Hikma Pharmaceuticals USA INC. Codes, lots and dates: Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026
What is the hazard?
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
How do I check if mine is affected?
Codes, lots and dates: Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026
Where was it distributed?
US Nationwide
Related recalls
- Hikma Pharmaceuticals USA INC.: Ciprofloxacin Tablets recall
- Hikma Pharmaceuticals USA INC.: Abirtega (abiraterone acetate) USP recall
- Hikma Pharmaceuticals USA INC.: Ramipril Capsules USP recall
- Greenwich: Compounded sterile products
- Breckenridge Pharmaceutical, Inc.: Propranolol Hydrochloride Extended-Release Capsules, USP, 60mg
- React Health dba 3B Medical, Inc.: Bilevel Positive Airway Pressure (BPAP) System
